Literature DB >> 10411380

Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role.

V Montenegro1, R C Monteiro.   

Abstract

Ankylosing spondylitis and IgA nephropathy share some immunologic features, eg, elevated serum IgA and IgA-immune complex levels. These entities are frequently found as being associated. IgA and IgA immune complex catabolism involves asialoglycoprotein receptors and specific IgA Fc receptors (FcalphaR or CD89) on tissue and blood cells. Recent studies revealed impaired CD89 expression in both diseases. These abnormalities, which are associated with receptor saturation, might generate the increase in serum IgA and IgA immune complex levels by either altered recycling or failure of degradation. This article reviews the literature on IgA abnormalities and discusses the potential role of FcalphaR in IgA nephropathy and AS and the consequences of its similar defect in the two diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411380     DOI: 10.1097/00002281-199907000-00007

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.

Authors:  Grigorios T Sakellariou; Periklis Vounotrypidis; Charalampos Berberidis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 2.980

2.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

Review 3.  Role of IgA and IgA fc receptors in inflammation.

Authors:  Renato C Monteiro
Journal:  J Clin Immunol       Date:  2009-10-16       Impact factor: 8.317

4.  Coexistence of IgA nephropathy and undifferentiated spondyloarthropathy in a female patient.

Authors:  Masayuki Matsuda; Akio Suzuki; Hiroshi Miyagawa; Seiichiro Shimizu; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2005-10-19       Impact factor: 2.980

5.  Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?

Authors:  Bayram Farisogullari; Muserref Kasap Cuceoglu; Hakan Oral; Gozde Kubra Yardimci; Yelda Bilginer; Seza Ozen; Omer Karadag
Journal:  Intern Emerg Med       Date:  2022-03-26       Impact factor: 5.472

Review 6.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 7.  Role of IgA receptors in the pathogenesis of IgA nephropathy.

Authors:  Sebastian M Lechner; Christina Papista; Jonathan M Chemouny; Laureline Berthelot; Renato C Monteiro
Journal:  J Nephrol       Date:  2015-11-14       Impact factor: 3.902

8.  Spectrums and Prognosis of Kidney Disease in Patients with Ankylosing Spondylitis.

Authors:  Dafeng He; Rong Wang; Shaoshan Liang; Dandan Liang; Feng Xu; Caihong Zeng; Zheng Tang
Journal:  Kidney Dis (Basel)       Date:  2020-08-26

9.  Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.

Authors:  P Launay; B Grossetête; M Arcos-Fajardo; E Gaudin; S P Torres; L Beaudoin; N Patey-Mariaud de Serre; A Lehuen; R C Monteiro
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

10.  Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.

Authors:  I C Moura; M N Centelles; M Arcos-Fajardo; D M Malheiros; J F Collawn; M D Cooper; R C Monteiro
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.